Editors’ Picks, November 2026: Less Toxic Immunotherapy, Targeting the Breast Cancer Microenvironment, Clinical Trials, and More
The November 2026 Editors’ Picks from AACR journals include a potential strategy to make immune checkpoint inhibitors less toxic...